A citation-based method for searching scientific literature

Eijiro Yamada, Shuichi Okada, Yasuyo Nakajima, Claire C Bastie, Manu Vatish, Yuko Tagaya, Aya Osaki, Yoko Shimoda, Ryo Shibusawa, Tsugumichi Saito, Takashi Okamura, Atsushi Ozawa, Masanobu Yamada. Endocr Pract 2017
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clinical outcomes in real-world patients with type 2 diabetes switching from first- to second-generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study.
Sean D Sullivan, Timothy S Bailey, Ronan Roussel, Fang Liz Zhou, Zsolt Bosnyak, Ronald Preblick, Jukka Westerbacka, Rishab A Gupta, Lawrence Blonde. Diabetes Obes Metab 2018
40
50

Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice.
Lawrence Blonde, Stephen A Brunton, Pavan Chava, Rong Zhou, Juliana Meyers, Keith L Davis, Mehul R Dalal, Andres DiGenio. Diabetes Spectr 2019
6
50




Real-world evidence concerning clinical and economic outcomes of switching to insulin glargine 300 units/mL vs other basal insulins in patients with type 2 diabetes using basal insulin.
Fang Liz Zhou, Fen Ye, Paulos Berhanu, Vineet E Gupta, Rishab A Gupta, Jennifer Sung, Jukka Westerbacka, Timothy S Bailey, Lawrence Blonde. Diabetes Obes Metab 2018
42
50

Achieve control: a pragmatic clinical trial of insulin glargine 300 U/mL versus other basal insulins in insulin-naïve patients with type 2 diabetes.
Gerry Oster, Sean D Sullivan, Mehul R Dalal, Mahmood R Kazemi, Maria Rojeski, Carol H Wysham, Jennifer Sung, Bryan Johnstone, Anna M G Cali, L J Wei,[...]. Postgrad Med 2016
11
50

Insulin glargine 300 units/mL: A new basal insulin product for diabetes mellitus.
Jennifer N Clements, Larkin Bello. Am J Health Syst Pharm 2016
10
50

Real-World Evidence - What Is It and What Can It Tell Us?
Rachel E Sherman, Steven A Anderson, Gerald J Dal Pan, Gerry W Gray, Thomas Gross, Nina L Hunter, Lisa LaVange, Danica Marinac-Dabic, Peter W Marks, Melissa A Robb,[...]. N Engl J Med 2016
742
50


External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants?
C Saunders, C D Byrne, B Guthrie, R S Lindsay, J A McKnight, S Philip, N Sattar, J J Walker, S H Wild. Diabet Med 2013
65
50

Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control.
Steven V Edelman, William H Polonsky. Diabetes Care 2017
124
50

Glycaemic goal attainment and hypoglycaemia outcomes in type 2 diabetes patients initiating insulin glargine 300 units/mL or 100 units/mL: Real-world results from the DELIVER Naïve cohort study.
Timothy S Bailey, Fang L Zhou, Rishab A Gupta, Ronald Preblick, Vineet E Gupta, Paulos Berhanu, Lawrence Blonde. Diabetes Obes Metab 2019
14
50


Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetes Care 2018
991
50

Role of continuous glucose monitoring for type 2 in diabetes management and research.
Robert Vigersky, Maneesh Shrivastav. J Diabetes Complications 2017
46
50

A1C: does one size fit all?
Robert M Cohen. Diabetes Care 2007
53
50

The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System.
Timothy Bailey, Bruce W Bode, Mark P Christiansen, Leslie J Klaff, Shridhara Alva. Diabetes Technol Ther 2015
302
50

Performance of the Freestyle Libre flash glucose monitoring (flash GM) system in individuals with type 1 diabetes: A secondary outcome analysis of a randomized crossover trial.
Othmar Moser, Max L Eckstein, Olivia McCarthy, Rachel Deere, Jason Pitt, David M Williams, Jennifer Hayes, Harald Sourij, Stephen C Bain, Richard M Bracken. Diabetes Obes Metab 2019
31
50

Translating the A1C assay into estimated average glucose values.
David M Nathan, Judith Kuenen, Rikke Borg, Hui Zheng, David Schoenfeld, Robert J Heine. Diabetes Care 2008
887
50

Relationship between HbA1c and continuous glucose monitoring in Chinese population: a multicenter study.
Jian Zhou, Yifei Mo, Hong Li, Xingwu Ran, Wenying Yang, Qiang Li, Yongde Peng, Yanbing Li, Xin Gao, Xiaojun Luan,[...]. PLoS One 2013
18
50

The interrelationship of HbA1c and real-time continuous glucose monitoring in children with type 1 diabetes.
Tamás Ferenci, Anna Körner, Levente Kovács. Diabetes Res Clin Pract 2015
8
50

Glucose Management Indicator (GMI): Insights and Validation Using Guardian 3 and Navigator 2 Sensor Data.
Lalantha Leelarathna, Roy W Beck, Richard M Bergenstal, Hood Thabit, Roman Hovorka. Diabetes Care 2019
8
50

Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring.
Dongyuan Xing, Craig Kollman, Roy W Beck, William V Tamborlane, Lori Laffel, Bruce A Buckingham, Darrell M Wilson, Stuart Weinzimer, Rosanna Fiallo-Scharer, Katrina J Ruedy. Diabetes Technol Ther 2011
55
50

Glucose variability: An emerging target for the treatment of diabetes mellitus.
Simona Frontoni, Paolo Di Bartolo, Angelo Avogaro, Emanuele Bosi, Giuseppe Paolisso, Antonio Ceriello. Diabetes Res Clin Pract 2013
85
50

Flash Glucose Monitoring: The Future Is Here.
Satish K Garg, Halis Kaan Akturk. Diabetes Technol Ther 2017
18
50

Shortfalls of the use of HbA1C-derived eAG in older adults with diabetes.
M N Munshi, A R Segal, C Slyne, A A Samur, K M Brooks, E S Horton. Diabetes Res Clin Pract 2015
18
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.